ES2188580T3 - Sistema para uso en un metodo de tratamiento terapeutico o de diagnostico. - Google Patents

Sistema para uso en un metodo de tratamiento terapeutico o de diagnostico.

Info

Publication number
ES2188580T3
ES2188580T3 ES90914303T ES90914303T ES2188580T3 ES 2188580 T3 ES2188580 T3 ES 2188580T3 ES 90914303 T ES90914303 T ES 90914303T ES 90914303 T ES90914303 T ES 90914303T ES 2188580 T3 ES2188580 T3 ES 2188580T3
Authority
ES
Spain
Prior art keywords
medical agent
therapeutic
diagnostic treatment
treatment method
normal clearance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90914303T
Other languages
English (en)
Inventor
Stephen W Maddock
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitra Medical Technology AB
Original Assignee
Mitra Medical Technology AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitra Medical Technology AB filed Critical Mitra Medical Technology AB
Application granted granted Critical
Publication of ES2188580T3 publication Critical patent/ES2188580T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • A61M1/3472—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration with treatment of the filtrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • A61M1/3472—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration with treatment of the filtrate
    • A61M1/3486—Biological, chemical treatment, e.g. chemical precipitation; treatment by absorbents

Landscapes

  • Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • External Artificial Organs (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Electrotherapy Devices (AREA)

Abstract

ES UN METODO DE TRATAMIENTO TERAPEUTICO O DIAGNOSTICO USANDO UN AGENTE MEDICO, EN EL CUAL HABRA EFECTOS BENEFICIOSOS SI EL NIVEL DE CIRCULACION DE DICHO AGENTE SE REDUCE ARTIFICIALMENTE MAS RAPIDAMENTE, QUE MEDIANTE LA REDUCCION POR EL ACLARAMIENTO NORMAL O POR VIAS QUE EVITEN LOS MECANISMOS NORMALES DE ACLARAMIENTO. EL METODO INCLUYE LA EXTRACCION EXTRACORPOREA DEL AGENTE MEDICO PASANDO EL LIQUIDO CORPORAL DEL PACIENTE POR UN SOPORTE ADAPTADO PARA EXTRAER SELECTIVAMENTE EL AGENTE MEDICO.-
ES90914303T 1989-08-02 1990-08-02 Sistema para uso en un metodo de tratamiento terapeutico o de diagnostico. Expired - Lifetime ES2188580T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US38866489A 1989-08-02 1989-08-02

Publications (1)

Publication Number Publication Date
ES2188580T3 true ES2188580T3 (es) 2003-07-01

Family

ID=23535010

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90914303T Expired - Lifetime ES2188580T3 (es) 1989-08-02 1990-08-02 Sistema para uso en un metodo de tratamiento terapeutico o de diagnostico.

Country Status (6)

Country Link
US (2) US5474772A (es)
EP (1) EP1327454A3 (es)
AT (1) ATE233100T1 (es)
DE (1) DE69034042T2 (es)
DK (1) DK0436717T3 (es)
ES (1) ES2188580T3 (es)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9100142L (sv) * 1991-01-17 1992-07-18 Bengt Sandberg En metod och ett system foer foerbaettrad in vivo reducering av diagnostiska och/eller terapeutiska substanser medelst extrakorporeal borttagning, och anvaendandet av naemnda substanser foer detta aendamaal
US5753227A (en) 1993-07-23 1998-05-19 Strahilevitz; Meir Extracorporeal affinity adsorption methods for the treatment of atherosclerosis, cancer, degenerative and autoimmune diseases
US7166295B1 (en) * 1995-05-26 2007-01-23 Meir Strahilevitz Methods of treatment and diagnostic visualization, particularly in cancer
US20010023288A1 (en) * 1999-07-07 2001-09-20 Wilbur D. Scott Trifunctional reagent for conjugation to a biomolecule
US8951499B2 (en) * 1996-02-08 2015-02-10 University Of Washington Trifunctional reagent for conjugation to a biomolecule
US7011812B1 (en) 1996-05-03 2006-03-14 Immunomedics, Inc. Targeted combination immunotherapy of cancer and infectious diseases
AU717020B2 (en) * 1996-05-03 2000-03-16 Immunomedics Inc. Targeted combination immunotherapy of cancer
US5817770A (en) 1997-03-21 1998-10-06 Drug Abuse Sciences, Inc. Cocaethylene immunogens and antibodies
US20050271673A1 (en) * 1998-07-07 2005-12-08 Wilbur D S Trifunctional reagent for conjugation to a biomolecule
WO2001097855A2 (en) * 2000-06-20 2001-12-27 Immunomedics, Inc. Targeted combination immunotherapy of cancer and infectious diseases
AU2001296124A1 (en) * 2000-10-12 2002-04-22 Mitra Medical Technology Ab Kit for intraperitoneal administration and extracorpeal removal of a drug
EP1575507A2 (en) * 2002-04-02 2005-09-21 Scantibodies Laboratory, Inc. Methods and devices for treating severe peripheral bacterial infections
US20050271653A1 (en) * 2002-04-23 2005-12-08 Meir Strahilevitz Methods and devices for targeting a site in a mammal and for removing species from a mammal
US20060030027A1 (en) * 2004-08-04 2006-02-09 Aspira Biosystems, Inc. Capture and removal of biomolecules from body fluids using partial molecular imprints
WO2006055813A2 (en) 2004-11-16 2006-05-26 Medrad, Inc. Modeling of pharmaceutical propagation
EP2392379A3 (en) 2004-11-24 2012-03-21 Medrad, Inc. Devices, systems and methods for fluid delivery
JP2006248978A (ja) * 2005-03-10 2006-09-21 Mebiopharm Co Ltd 新規なリポソーム製剤
DK2097835T3 (en) 2006-12-29 2018-09-03 Bayer Healthcare Llc PATIENT-BASED PARAMETER GENERATION SYSTEMS FOR MEDICAL INJECTION PROCEDURES
JP5437240B2 (ja) 2007-07-17 2014-03-12 メドラッド インコーポレーテッド 心肺機能の評価、及び流体搬送の手順のパラメータを決定する装置、システム及び方法
US8165663B2 (en) * 2007-10-03 2012-04-24 The Invention Science Fund I, Llc Vasculature and lymphatic system imaging and ablation
US8285367B2 (en) * 2007-10-05 2012-10-09 The Invention Science Fund I, Llc Vasculature and lymphatic system imaging and ablation associated with a reservoir
US8285366B2 (en) 2007-10-04 2012-10-09 The Invention Science Fund I, Llc Vasculature and lymphatic system imaging and ablation associated with a local bypass
US9421330B2 (en) 2008-11-03 2016-08-23 Bayer Healthcare Llc Mitigation of contrast-induced nephropathy
US8317737B2 (en) 2009-02-25 2012-11-27 The Invention Science Fund I, Llc Device for actively removing a target component from blood or lymph of a vertebrate subject
US8246565B2 (en) 2009-02-25 2012-08-21 The Invention Science Fund I, Llc Device for passively removing a target component from blood or lymph of a vertebrate subject
US8454547B2 (en) * 2009-02-25 2013-06-04 The Invention Science Fund I, Llc Device, system, and method for controllably reducing inflammatory mediators in a subject
US8758330B2 (en) 2010-03-05 2014-06-24 The Invention Science Fund I, Llc Device for actively removing a target cell from blood or lymph of a vertebrate subject
US20110295175A1 (en) * 2010-03-16 2011-12-01 Marv Enterprises Llc Sequential Extracoporeal Treatment of Bodily Fluids
WO2011163578A2 (en) 2010-06-24 2011-12-29 Medrad, Inc. Modeling of pharmaceutical propagation and parameter generation for injection protocols
CN111528872A (zh) 2012-05-14 2020-08-14 拜耳医药保健有限公司 用于基于x射线管电压确定药用流体注射协议的系统和方法
US9555379B2 (en) 2013-03-13 2017-01-31 Bayer Healthcare Llc Fluid path set with turbulent mixing chamber, backflow compensator
US10898638B2 (en) 2016-03-03 2021-01-26 Bayer Healthcare Llc System and method for improved fluid delivery in multi-fluid injector systems
CN109996809A (zh) 2016-11-14 2019-07-09 诺华股份有限公司 与促融合蛋白minion相关的组合物、方法和治疗用途
EP3538182A1 (en) 2016-11-14 2019-09-18 Bayer Healthcare LLC Methods and systems for verifying the contents of a syringe used for medical fluid delivery
EP3675931B1 (en) 2017-08-31 2021-08-11 Bayer Healthcare LLC Injector pressure calibration system and method
AU2018323442B2 (en) 2017-08-31 2024-06-27 Bayer Healthcare Llc Fluid path impedance assessment for improving fluid delivery performance
US11779702B2 (en) 2017-08-31 2023-10-10 Bayer Healthcare Llc Method for dynamic pressure control in a fluid injector system
WO2019046259A1 (en) 2017-08-31 2019-03-07 Bayer Healthcare Llc SYSTEM AND METHOD COMPRISING A TRANSITION PHASE IN A MULTIPHASE INJECTION PROTOCOL
JP7317724B2 (ja) 2017-08-31 2023-07-31 バイエル・ヘルスケア・エルエルシー 液注入器システムの容積補償システムおよび方法
JP7252143B2 (ja) 2017-08-31 2023-04-04 バイエル・ヘルスケア・エルエルシー 駆動部材の位置及び流体注入器システムの機械的較正のためのシステム及び方法
GB201717555D0 (en) * 2017-10-25 2017-12-06 Nonwovens Innovation & Res Institute Ltd Blood filter
WO2019204605A1 (en) 2018-04-19 2019-10-24 Bayer Healthcare Llc System and method for air detection in fluid injector
CA3111209A1 (en) 2018-08-28 2020-03-05 Bayer Healthcare Llc Fluid injector system with improved ratio performance
CA3110859A1 (en) 2018-08-28 2020-03-05 Bayer Healthcare Llc Fluid injector system, method of preventing fluid backflow, and computer program product
MX2023006142A (es) * 2020-11-25 2023-07-26 Cytostorm Inc Sistemas y metodos extracorporeos para la separacion, adsorcion y suministro de plasma.

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4375414A (en) * 1971-05-20 1983-03-01 Meir Strahilevitz Immunological methods for removing species from the blood circulatory system and devices therefor
US4371515A (en) * 1978-12-26 1983-02-01 E-Y Laboratories, Inc. Method for forming an isolated lectin-immunological conjugate
US4223672A (en) * 1979-02-08 1980-09-23 Baxter Travenol Laboratories, Inc. Variable volume plasma treatment chamber for an apparatus for the extracorporeal treatment of disease
US4215688A (en) * 1979-02-09 1980-08-05 Baxter Travenol Laboratories, Inc. Apparatus for the extracorporeal treatment of disease
US4350156A (en) * 1980-05-29 1982-09-21 Japan Foundation For Artificial Organs Method and apparatus for on-line filtration removal of macromolecules from a physiological fluid
US4824432A (en) * 1981-03-24 1989-04-25 S.V.S. Laboratories, Inc. Method for treating AIDS and other immune deficiencies and immune disorders
US4687808A (en) * 1982-08-12 1987-08-18 Biospecific Technologies, Inc. Activation of biocompatible polymers with biologicals whose binding complements are pathological effectors
CA1221307A (en) * 1982-12-02 1987-05-05 Nobutaka Tani Adsorbent and process for preparing the same
CA1236738A (en) * 1983-06-01 1988-05-17 Mark R. Honard Therapeutic device
US4551435A (en) * 1983-08-24 1985-11-05 Immunicon, Inc. Selective removal of immunospecifically recognizable substances from solution
DK525384D0 (da) * 1984-11-05 1984-11-05 Nordisk Insulinlab Praeparat paa basis af faktor viii til behandling af haemofili a inhibitorpatienter samt fremgangsmaade til fremstilling af et saadan praeparat
US4863713A (en) * 1986-06-23 1989-09-05 The Board Of Trustees Of Leland Stanford Jr. Univ. Method and system for administering therapeutic and diagnostic agents
US4877599A (en) * 1986-11-10 1989-10-31 New England Deaconess Hospital Corporation Detection of vascular disease with labelled antibodies
US5122112A (en) * 1986-11-21 1992-06-16 Imre Corporation Antigen-specific removal of circulating immune complexes
US4800016A (en) * 1986-11-24 1989-01-24 The University Of Michigan Extracorporeal blood de-heparinization system
DE3705637A1 (de) * 1987-02-21 1988-09-29 Bissendorf Peptide Gmbh Vorrichtung zur entfernung von lokal applizierten wirkstoffen gegen solide tumoren
US4846786A (en) * 1987-04-30 1989-07-11 Massachusetts Institute Of Technology Bioreactor containing suspended, immobilized species
US4885207A (en) * 1987-07-13 1989-12-05 Uop Biocompatible protein or ligand immobilization system
US4865841A (en) * 1987-10-23 1989-09-12 Imre Corporation Methods and compositions for transient elimination of humoral immune antibodies
US5069662A (en) * 1988-10-21 1991-12-03 Delcath Systems, Inc. Cancer treatment
US5149425A (en) * 1988-11-09 1992-09-22 Chembiomed, Ltd. Affinity supports for hemoperfusion
CA2025899A1 (en) * 1989-01-23 1990-07-24 Reinhard Bredehorst Site specific in-vivo activation of therapeutic drugs
US5252466A (en) * 1989-05-19 1993-10-12 Biotechnology Research And Development Corporation Fusion proteins having a site for in vivo post-translation modification and methods of making and purifying them
EP0436717B1 (en) * 1989-08-02 2003-02-26 Mitra Medical Technology AB System for use in a method of therapeutic or diagnostic treatment
SE9100142L (sv) * 1991-01-17 1992-07-18 Bengt Sandberg En metod och ett system foer foerbaettrad in vivo reducering av diagnostiska och/eller terapeutiska substanser medelst extrakorporeal borttagning, och anvaendandet av naemnda substanser foer detta aendamaal

Also Published As

Publication number Publication date
DE69034042T2 (de) 2003-07-17
US6046225A (en) 2000-04-04
DK0436717T3 (da) 2003-05-05
ATE233100T1 (de) 2003-03-15
EP1327454A2 (en) 2003-07-16
DE69034042D1 (de) 2003-04-03
EP1327454A3 (en) 2003-12-03
US5474772A (en) 1995-12-12

Similar Documents

Publication Publication Date Title
DK0436717T3 (da) System til anvendelse ved en fremgangsmåde til terapeutisk eller diagnostisk behandling
BR8203384A (pt) Sistema para tratamento do sangue de um paciente
SE9100142D0 (sv) A method and a system for enhanced in vivo clearance of diagnostic and/or therapeutic agents by extracorporeal depletion, and the use of said agents for said purpose
ES2022856B3 (es) Dispositivo para el tratamiento de la sangre en circulaciones extracorporales
BR9914969A (pt) Métodos para formar imagem, tratar e localizar tecido doente, e, dispositivo integrado de formação de imagem e de tratamento
ES556380A0 (es) Un dispositivo medico para la administracion transdermica de un agente biologico
DE68907402D1 (de) Durchflussregler fuer medizinloesungen oder fuer bluttransfusionsgeraete.
DE58908452D1 (de) Medizinisches Gerät zur Diagnose und/oder Therapie.
ES2020264B3 (es) Aparato de valvulas mejorado para sistemas de tratamiento de pacientes por fotoactivacion
Cunliffe et al. Treatment of Behcet's syndrome with phenformin and ethyloestrenol
MX155537A (es) Sistema terapeutico para tratamiento extracorporal
CA2037933A1 (en) Method of Treatment with Medical Agents
GB2108400A (en) Method and apparatus for treating blood and the like
IT7822027A0 (it) Apparecchio medicale per la cura della trombosi venale profonda.
ES515833A0 (es) "perfeccionamientos en las instalaciones para la depuracion biologica de agua o aguas residuales".
ES2101311T3 (es) Utilizacion de un dispositivo transdermico que contiene (e)-2-(p-fluorofenetil)-3-fluoroalilamina y su uso para el tratamiento de la enfermedad de alzheimer.
FI875325A7 (fi) Näkyvänvalonsäteilyttäjälaite lääketieteelliseen käyttöön.
DE3650368D1 (de) Verwendung von Depogen zur Behandlung von eingeschränktem Blutkreislauf.
RU96115737A (ru) Способ определения показаний к проведению гормонотерапии у больных генитальным эндометриозом
IT8148480A0 (it) Composizione terapeutica e sistema per il trattamento extracorporeo di sangue intero
SU826588A1 (ru) Способ консервативного лечени неврологических синдромов при шейном остеохондрозе
ES556906A0 (es) Sistema de control de la temperatura de la sangre de un paciente en cirujia cardiaca
NO960866D0 (no) Fremgangsmåte til behandling av leversykdom og lignende indikasjoner med vasodilaterende midler
IT8819818A0 (it) Metodo per il controllo quantitativo del mutamento di posizione o il riposizionamento di pazienti nel rilievo di immagini radiografiche e/o in terapie per irraggiamento.
ITMI941157A0 (it) Apparato magnetoterapico per la riattivazione della circolazione sanguigna per il lenimento di mialgie, dolori articolari per la cura di traumi muscolari o simili